Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2009 | Hapten-derivatized nanoparticle targeting and imaging of gene expression by multimodality imaging systems. | Cheng, CM; Chu, PY; Chuang, KH; Roffler, SR; Kao, CH; Tseng, WL; Shiea, J; Chang, WD; Su, YC; Chen, BM; Wang, YM; Cheng, TL | Cancer Gene Therapy 16, 83-90 | | | |
2014 | High-throughput sorting of the highest producing cell via a transiently protein-anchored system. | Chuang, KH; Hsieh, YC; Chiang, IS; Chuang, CH; Kao, CH; Cheng, TC; Wang, YT; Lin, WW; Chen, BM; Roffler, SR; Huang, MY; Cheng, TL | PloS one 9(7), e102569 | | | |
2021 | Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice | Chang, TC; Chen, BM; Wu, JY; Cheng, TL; Roffler, S | Biomedicine & pharmacotherapy 146, 112502 | | | |
2015 | Impediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapy. | Hsieh, YT; Chen, KC; Cheng, CM; Cheng, TL; Tao, MH; Roffler, SR | PloS one 10(2), e0118028 | | | |
2011 | In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a non-inhibitory protease substrate. | Cheng, TL; Chuang, CH; Chuang, KH; Wang, HE; Roffler, SR; Shiea, JT; Tzou, SC; Wu, SY; Cheng, TC; Kao, CH; Cheng, CM; Tseng, WL; Hou, MF; Wang, JM | CLINICAL CANCER RESEARCH 18(1), 238-247 | | | |
2022 | Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis | Cheng, KW; Tseng, CH; Chen, IJ; Huang, BC; Liu, HJ; Ho, KW; Lin, WW; Chuang, CH; Huang, MY; Leu, YL; Roffler, SR ; Wang, JY; Chen, YL; Cheng, TL | Pharmacological research 177, 106115 | | | |
2010 | Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA. | Chuang, KH; Tzou, SC; Cheng, TC; Kao, CH; Tseng, WL; Shiea, J; Liao, KW; Wang, YM; Chang, YC; Huang, BJ; Wu, CJ; Chu, PY; Roffler, SR; Cheng, TL | Analytical chemistry 82(6), 2355-2362 | | | |
2016 | Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals. | Chen, BM; Su, YC; Chang, CJ; Burnouf, PA; Chuang, KH; Chen, CH; Cheng, TL; Chen, YT; Wu, JY; Roffler, SR | Analytical chemistry 88(21), 10661-10666 | | | |
2009 | Micro-PET imaging of beta-glucuronidase activity by the hydrophobic conversion of a glucuronide probe. | Tzou, SC; Roffler, S; Chuang, KH; Yeh, HP; Kao, CH; Su, YC; Cheng, CM; Tseng, WL; Shiea, J; Harm, IH; Cheng, KW; Chen, BM; Hwang, JJ; Cheng, TL; Wang, HE. | Radiology 252(3), 754-762 | | | |
2005 | Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles. | Cheng, TL; Cheng, CM; Chen, BM; Tsao, DA; Chuang, KH; Hsiao, SW; Lin, YH; Roffler, SR | Bioconjugate Chemistry 16, 1225-1231 | | | |
2014 | One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles. | Kao, CH; Wang, JY; Chuang, KH; Chuang, CH; Cheng, TC; Hsieh, YC; Tseng, YL; Chen, BM; Roffler, SR; Cheng, TL | Biomaterials 35(37), 9930-9940 | | | |
2014 | PET Imaging of beta-Glucuronidase Activity by an Activity-Based 124I-Trapping Probe for the Personalized Glucuronide Prodrug Targeted Therapy. | Su, YC; Cheng, TC; Leu, YL; Roffler, SR; Wang, JY; Chuang, CH; Kao, CH; Chen, KC; Wang, HE; Cheng, TL | Molecular Cancer Therapeutics 13(12), 2852-2863 | | | |
2021 | Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies | Chen, BM; Cheng, TL; Roffler, SR | ACS nano 15(9), 14022-14048 | | | |
2020 | Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex | Chen, E; Chen, BM; Su, YC; Chang, YC ; Cheng, TL; Barenholz, Y; Roffler, SR | ACS nano 14(7), 7808-7822 | | | |
2015 | Selective Delivery of PEGylated Compounds to Tumor Cells by anti-PEG Hybrid Antibodies. | Tung, HY; Su, YC; Chen, BM; Burnouf, PA; Huang, WC; Chuang, KH; Yan, YT; Cheng, TL; Roffler, SR | Molecular cancer therapeutics Epub ahead of print | | | |
2010 | Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies. | Su, YC; Chen, BM; Chuang, KH; Cheng, TL; Roffler, SR | Bioconjugate chemistry 21(7), 1264-1270 | | | |
2019 | Simply Mixing Poly Protein G with Detection Antibodies Enhances the Detection Limit and Sensitivity of Immunoassays. | Chen, YJ; Chen, M; Cheng, TL; Roffler, SR ; Lin, SY; Hsu, HL; Wang, CH; Chen, CY; Kao, AP; Cheng, JJ; Chuang, KH | Analytical chemistry 91(13), 8310-8317 | | | |
2022 | Structural determination of an antibody that specifically recognizes polyethylene glycol with a terminal methoxy group | Nguyen, MT; Shih, YC; Lin, MH; Roffler, SR ; Hsiao, CY; Cheng, TL; Lin, WW; Lin, EC; Jong, YJ; Chang, CY; Su, YC | Communications chemistry 5(1), 88 | | | |
2016 | Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation. | Prijovich, ZM; Burnouf, PA; Chou, HC; Huang, PT; Chen, KC; Cheng, TL; Leu, YL; Roffler, SR | Molecular pharmaceutics 13(4), 1242-50 | | | |
2016 | Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles. | Hsieh, YC; Cheng, TC; Wang, HE; Li, JJ; Lin, WW; Huang, CC; Chuang, CH; Wang, YT; Wang, JY; Roffler, SR; Chuang, KH; Cheng, TL | Scientific reports 6, 39119 | | | |